Envestnet Asset Management
TRPX

Envestnet Asset Management’s Therapix Biosciences Ltd. TRPX Stock Holding History

Envestnet Asset Management’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,018
Closed -$6K – 3244
2020
Q2 		$6K Buy
+10,018
New +$4.83K ﹤0.01% 3059

Envestnet Asset Management's TRPX Position: Q3 2020 in Review

Envestnet Asset Management sold out of Therapix Biosciences Ltd. (TRPX) in Q3 2020, closing a stake of 10,018 shares — an estimated $6K sold.

Envestnet Asset Management first reported a position in TRPX in Q2 2020 and held it in 1 quarter. The position peaked at $6K in Q2 2020. 0 funds tracked by Wall St. Rank hold TRPX as of Q3 2020.

  • Envestnet Asset Management reported no remaining Therapix Biosciences Ltd. position as of Q3 2020 after selling out during the quarter.
  • Envestnet Asset Management sold 10,018 Therapix Biosciences Ltd. shares in Q3 2020, an estimated $6K.
  • Envestnet Asset Management first reported a position in Therapix Biosciences Ltd. in Q2 2020 and held it in 1 quarter.
  • Envestnet Asset Management's Therapix Biosciences Ltd. position peaked at $6K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q3 2020.

Based on Envestnet Asset Management's 13F filing for Q3 2020, filed 9 Oct 2020.